1. Fusion PharmacologyTHE BEST OF BOTH WORLDS
Access the Asia Pacific Region with Confidence
FUSION’S NORTHERN PARTNER ARRIVES
The partners of Fusion Pharmacology, the rapidly
evolving APAC early Clinical Pharmacology Group
have been joined by a Northern Participant in the
collaborative membership of the group.
Re-awakening an old collaboration between the
Phase I Unit at Kitasato University and Veeda
Clinical Research in Plymouth UK, we are now able
to offer the advantages of joint studies between the
two units.
Prof Yuji Kumagai and his team have been leaders
in developing collaborations between all the major Northern Asian Countries such as
China, Taiwan and Korea through a collaborative network and we are pleased that this first
step enables the members of the Fusion group to
develop in the greater Asian market.
Our intention is to utilise the multi-ethnicity of APAC
and our contacts with Kitasato to offer to our client base a
a fast, effective and easy way to write bridging studies
into their early clinical development programmes.
The Asian Clinical Pharmacology network developed by
Prof Kumagai has links on a global basis.
For more information about how you might
take advantage of this new dimension to our
partnership please contact:
Elizabeth.Stevens@fusionseasia.com
Or
Yvonne.Lungershausen@cprpharma.com